Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

By Proactive Investors / December 28, 2023 / www.youtube.com / Article Link


Tonix Pharmaceuticals CEO Dr. Seth Lederman recently recently shared groundbreaking news during an interview with Steve ...

Recent News

Gold stocks slump partly on fears of cost increases
March 09, 2026 / www.canadianminingreport.com

Canadian provinces rank high in Fraser Institute Survey
March 09, 2026 / www.canadianminingreport.com

Major producers and most of TSXV gold see strong gains
March 03, 2026 / www.canadianminingreport.com

Big Gold production declining, revenue surging, costs flat
February 23, 2026 / www.canadianminingreport.com

Gold stocks rise with majors outpaced by juniors
February 23, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok